Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

ARUK Network 2016

Our network is a collaboration between various departments at Oxford University, Oxford Brookes University and Reading University.

To find out more about being part of the Network Centre, contact us at aruk.administrator@dpag.ox.ac.uk / tel: 01865 282358.

Many of our members are also part of the OxDARE research network whose directory can be searched here.

Oxford ARUK Organising Committee

 Name:

Institution:

Mark DallasMark Dallas

Department of Pharmacy, University of Reading

@drmarkdallas

Working to unravel new therapeutic targets for a host of neurodegenerative diseases

Angela BithellA Bithell

Department of Pharmacy, University of Reading

Interested in the molecular and cellular mechanisms that underlie normal developmental of the central nervous system (CNS) and CNS-related disorders.

Christopher ButleChris Butlerr

Nuffield Department of Clinical Neurosciences, University of Oxford

Research focusses on understanding the memory deficits experienced by patients with damage to the medial temporal lobes of the brain.

Steven ChanceSteven Chance

Nuffield Department of Clinical Neurosciences, University of Oxford

Interested in the relationship between brain structure and function - particularly language and social cognition

Helen DawesHelen Dawes

Faculty of Health and Life Sciences at Oxford Brookes University

@helendawes2

Research spans from exploring underlying mechanisms affecting performance through to service delivery of subsequently developed interventions and tools.

Research has three themes:  movement, rehabilitation and exercise.

Patrick EsserPatrick Esser

Movement Science Group,  Oxford Brookes University.

Research interests lie within the broad field of biomechanics with a particular interest in movement analysis in (non-) neurological conditions. 

Simon LovestoneSimon Lovestone

Department of Psychiatry, University of Oxford

@Simon_Lovestone

Research on the molecular pathogenesis of and biomarkers for Alzheimer's disease.

Clare MackayClare MacKay

Department of Psychiatry, University of Oxford

@ClareEMacKay  @OxDARE

Research focuses on using neuroimaging to understand risk for psychiatric and neurodegenerative disease.

Rupert McShaneRupert McShane

DeNDRoN / Oxford University Hospitals NHS Trust

Interested in dementia and in treatment resistant depression.  Leads the Thames Valley DeNDRoN local research network, which supports a wide variety of studies in dementia and neurological disease

Richard Wade-MartinsRichard Wade-Martins

Department of Physiology, Anatomy and Genetics, University of Oxford

@WadeMartinsLab

Works on understanding molecular mechanisms of age-related neurodegenerative diseases to generate novel molecular therapies

 

Current members of the Oxford Network Centre

Neuroscience, Molecular Biology, primary cell culture

Clinical neurology, neuroimaging, cognition

Name

Affiliation

 

Members A-C

Bryan Adriaanse

Nuffield Department of Clinical Neurosciences, University of Oxford

Cellular and molecular biology

Devika Agarwal*

ODDI/Department of Physiology, Anatomy and Genetics, University of Oxford

Bioinformatics

Samrah Ahmed

Nuffield Department of Clinical Neurosciences, University of Oxford

Cognitive tests, neuropsychology

Colin Akerman

Department of Pharmacology, University of Oxford

Cellular and molecular biology

Zoi Alexopoulou

Nuffield Department of Clinical Neurosciences, University of Oxford

Fly genetics, cell-based assays, genomics and neuropathology

Joshua Almond-Thynne*

Alzheimer's Research UK Oxford Drug Discovery Institute

 

Sneha Anand

Department of Psychiatry. University of Oxford

Blood & CSF analysis, cellular and molecular biology

Olaf Ansorge

Nuffield Department of Clinical Neurosciences, University of Oxford

Molecular neuropathology

Kanisa Arunasalam*

Nuffield Department of Clinical Neurosciences, University of Oxford

Microbiology, cell biology, biotechnology

Alison Baird

Department of Psychiatry. University of Oxford

Blood & CSF analysis, cellular and molecular biology, cohorts, imaging

Imelda Barber

Department of Psychiatry. University of Oxford

Molecular Biology, Biostatistics, Bioinformatics

Dayne Beccano-Kelly*

 

Department of Physiology, Anatomy and Genetics, University of Oxford

Electrophysiology, cellular and molecular biology

Jill Betts

Department of Psychiatry and FMRIB Centre at the University of Oxford

Fitness training with MRI scanning and cognitive assessment

Angela Bithell

Department of Pharmacy, University of Reading

Cellular and molecular biology

Chas Bountra*

Structural Genomics Consortium, University of Oxford

Structural Genomics Consortium Chief Scientist, Protein Science and Structural Biology

Paul Brennan

Structural Genomics Consortium, University of Oxford

Epigenetics,  target discovery, parallel organic synthesis

Joanne Brooke*

Oxford Institute of Nursing, Midwifery and Allied Health Research (OxINMAHR)

Faculty of Health and Life Sciences, Oxford Brookes University

Reader in Complex Older Persons Care

Lead of the International Dementia and Culture Collaborative (IDCC)

Christopher Butler

Nuffield Department of Clinical Neurosciences, University of Oxford

Experimental psychology & cognitive neuroscience, electrophysiology (EEG), imaging

Tara Caffrey

Department of Physiology, Anatomy and Genetics, University of Oxford

Cellular and molecular biology, genetics & genomics

Phillippa Carling

Department of Physiology, Anatomy and Genetics, University of Oxford

Cell Biology, Molecular Biology, Neuroscience, target discovery, iPSc

Anna Cederbalk*

Alzheimer's Research UK Oxford Drug Discovery Institute

Target Discovery

Steven Chance

Nuffield Department of Clinical Neurosciences, University of Oxford

Imaging, neuropathology

Jonathan Cheung*

Nuffield Department of Clinical Neurosciences, University of Oxford

 

Sharon Christie

Nuffield Department of Clinical Neurosciences, University of Oxford

Clinical research nurse

Helen Collins

DeNDRoN / Oxford University Hospitals NHS Trust

Research delivery manager

Sally Cowley

James Martin Stem Cell Facility, William Dunn School of Pathology

Cellular and molecular biology, genetics & genomics

Members D-I

Mark Dallas

Department of Pharmacy, University of Reading

Cellular and molecular biology, electrophysiology (EEG), imaging, pharmacology

Ruxandra Mutihac Dafinca

Nuffield Department of Clinical Neurosciences, University of Oxford

iPSc, ALS, FTD, phenotypes, drug discovery

Adria Dangla Valls

Department of Psychiatry. University of Oxford

 iPSc, clusterin, henotypic readout, rodent models

John Davis

Alzheimer's Research UK Oxford Drug Discovery Institute

CSO of ARUK Oxford Drug Discovery Institute

Helen Dawes

Faculty of Health and Life Sciences at Oxford Brookes University

Movement, rehabilitation and exercise 

Stephane De Cesco

Target Discovery Institute, Oxford

Computational chemistry, target discovery

Gabriele De Luca

Nuffield Department of Clinical Neurosciences, University of Oxford

Cellular and molecular biology, genetics & genomics, neuropathology 

Naiara Demnitz

Department of Psychiatry, University of Oxford

MRI, cognitive psychology, exercise, brain structure and function

Elena Di Daniel

Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford

Target validation, drug discovery, iPSc

Sarah Dixon-Clarke

Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford

Structural Biology, X-ray crystallography

Matthias Ehebauer

Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford

Biotechnology, molecular biology, structural biology

Katherine England

Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford

 Discovery of chemical probes

Margaret Esiri

Nuffield Department of Clinical Neurosciences, University of Oxford

Genetics & genomics, neuropathology

Patrick Esser

Movement Science Group, Oxford Brookes University

Biomechanics, movement analysis

Oleg Fedorov

Structural Genomics Consortium, University of Oxford

Chemical probe discovery, Epigenetics

Ana Ferreira da Silva*

Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford

Cellular and molecular biology

Nicola Filippini

Department of Psychiatry, University of Oxford

Epidemiology/ cohort studies, fMRI, MRI

Evangeline Foster Department of Psychiatry, University of Oxford

Clusterin protein, CRISPR/CAS-9, iPSc

Menuka Pallebage Gamarallage

Nuffield Department of Clinical Neurosciences, University of Oxford

In vivo physiology, behaviour, histology

Mariacarmela Giurrandino

Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford

Drug discovery, screening, pharmacology

Ludovica Griffanti Nuffield Department of Clinical Neurosciences, University of Oxford MRI, multi-modal imaging, biomarkers

Walther Haenseler

James Martin Stem Cell Facility, Sir William Dunn School of Pathology

Cellular and molecular biology

Anne-Marie Haigh

Nuffield Department of Clinical Neurosciences, University of Oxford

Cognitive tests, fMRI, genetics, histopathology, neuropsychology

Maya Hanspal*

Alzheimer's Research UK's Oxford Drug Discovery Institute

Translational neuroscientis, Cellular biology

Cheryl Hawkes

Department of Life, Health & Chemical Sciences, Open University

Transgenic models, cellular and molecular biology, neuropathology

Anja Hayen

School of Psychology & Clinical Language Sciences, University of Reading

Nutrition, cognition and healthy ageing

Members J-M

 

 

Catherine Joachim

Nuffield Department of Clinical Neurosciences, University of Oxford

 

Timothy Johanssen

ARUK Oxford Drug Discovery Institute, University of Oxford

Protein aggregation, molecular neurobiology,  cell culture, prion protein, rna technology

Carole Johnston

Department of Pharmacology, University of Oxford

Lab manager

Keely Jones

ARUK Oxford Drug Discovery Institute, University of Oxford

Oxford Drug Discovery Institute Administrator

Mindaugas Jonikas*

Department of Physiology, Anatomy and Genetics, University of Oxford

Cell biology, molecular biology, neuroscience

Eleni Kaisis

Reading School of Pharmacy

Cell biology, molecular biology, neuroscience

Loukia Katsouri

ARUK Oxford Drug Discovery Institute, University of Oxford

Histology, neuroscience, physiology

Chi-Hun Kim

Department of Psychiatry, University of Oxford

Clinical bioinformatics

*Andrey Kormilitzin

Department of Psychiatry, University of Oxford

Stochastic analysis, numerical methods for PDE's
Statistical machine learning and data mining

Ivan Koychev

Department of Psychiatry, University of Oxford

Biomarkers, psychiatry

Charmaine Lang

Department of Physiology, Anatomy and Genetics, University of Oxford

Cellular and molecular biology, genetics & genomics

Jennifer Lawson

Department of Psychiatry, University of Oxford

Phenotyping, biomarkers

Cecilia (Heyne) Lee

James Martin Stem Cell Facility, Sir William Dunn School of Pathology

Cellular and molecular biology

Donald Lehmann

Department of Pharmacology, University of Oxford

Genetic epidemiology

Simon Lovestone

Department of Psychiatry, University of Oxford

 Clinical trials, cohorts

Clare Mackay

Department of Psychiatry, University of Oxford

Experimental psychology and cognitive neuroscience, genetics & genomics, imaging

Sebastian Mathea

ARUK Oxford Drug Discovery Institute, University of Oxford

Drug discovery

Jenny McCleery

DeNDRoN / Oxford University Hospitals NHS Trust

Clinical trials

Ellen McCulloch

Nuffield Department of Medicine, University of Oxford

Clinical research nurse

Rupert McShane

DeNDRoN / Oxford University Hospitals NHS Trust

Clinical trials, pharmacology, service evaluation

Claire Merritt

DeNDRoN / Oxford University Hospitals NHS Trust

Lead research nurse manager

Emma Murphy

ARUK Oxford Drug Discovery Institute

 

Susannah Murphy

Oxford Centre for Human Brain Activity, University of Oxford

Experimental psychology & cognitive neuroscience, imaging, genetics & genomics

Members N-R

 

 

Alejo Nevado-Holgado

Department of Psychiatry, University of Oxford

Cellular and molecular biology, clinical trials, cohorts, epidemiology /cohort studies, genetics & genomics, neuropathology, pharmacology

Danielle Newby

Department of Psychiatry, University of Oxford

Computational methods, healthy ageing

Bryan Ng

Department of Physiology, Anatomy and Genetics, University of Oxford

 Cellular and molecular biology

Francesca Nicholls

Department of Psychiatry, University of Oxford

ARUK Early Careers Representative

Cellular biology, high-throughput screening

Sohaib Nizami

Nuffield Department of Medicine, University of Oxford Neuroscience, Molecular Biology, primary cell culture

Shereen Nizari

Department of Life, Health & Chemical Sciences, Open University

Neuroscience, histology, cell biology

Kia Nobre

Department of Experimental Psychology, University of Oxford Experimental psychology & cognitive neuroscience, imaging

Laura Parkkinen

Nuffield Department of Clinical Neurosciences, University of Oxford

Transgenic models, blood & CSF analysis, cognitive tests, genetics, histopathology, immunohistochemistry molecular biology

Sarah Pendlebury

Nuffield Department of Clinical Neurosciences, University of Oxford

Cohorts, experimental psychology & cognitive neuroscience, service evaluation

Richard Priestley

Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford

Target validation and assay development

Cynthia Prendergast

Department of Pharmacology, University of Oxford

Pharmacology

Ilaria Poggiolini

Nuffield Department of Clinical Neurosciences, University of Oxford

Biomarkers, neuropathology

Clare Rathbone

Department of Psychology, Oxford Brookes University

Cognitive psychology

Elena Ribe

Department of Psychiatry, University of Oxford

Translational Neuroscience, animal models

Helga Refsum

Department of Pharmacology, University of Oxford

Blood & CSF analysis, clinical trials, epidemiology/cohort studies, genetics & genomics

Jacqueline Robbins

Target Discovery Institute, University of Oxford

Translational Neuroscience, cellular & molecular biology

Hazel Hall-Roberts

ARUK Oxford Drug Discovery Institute, and the James Martin Stem Cell Facility, University of Oxford.

Microglia, iPSc, cellular & molecular biology

David Ruvolo

Department of Psychiatry, University of Oxford

Project coordinator for the European Prevention of Alzheimer's Disease (EPAD) project

Brent Ryan

Department of Physiology, Anatomy and Genetics, University of Oxford

Phenotypes, high-throughput screens, iPSc, mass spectrometry

Members S-Z

 

 

Cynthia Sandor

Department of Physiology, Anatomy and Genetics, University of Oxford

Bioinformatics

Irene Sechi

Target Discovery Institute, University of Oxford

Target discovery

Claire Sexton

Department of Psychiatry, University of Oxford

Cohorts, imaging

*Liu Shi

Department of Psychiatry, University of Oxford

Blood based biomarkers

Carolyn Sloan

Nuffield Department of Clinical Neurosciences, University of Oxford

Laboratory manager, Neuropathology department

David Smith

Department of Pharmacology, University of Oxford

Pharmacology, imaging

Sana Suri

Department of Psychiatry, University of Oxford

Genetics, MRI, neuroimaging

Aleksandra Szykowska

Structural Genomics Consortium, Oxford University

Crystallography, protein purification

Kevin Talbot

Nuffield Department of Clinical Neurosciences, University of Oxford

Transgenic models, cellular & molecular biology, clinical trials

*Francesco Tamagnini

Department of Pharmacology, University of Reading

Cellular biology, electrophysiology, tauopathy and amyloidopathy

Laura Thei 

Department of Pharmacology, University of Reading

Transgenic models, cellular and molecular biology, imaging, neuropathology

George Tofaris

Nuffield Department of Clinical Neurosciences, University of Oxford

 Cellular and molecular biology

Mario Torso

Nuffield Department of Clinical Neurosciences, University of Oxford

Experimental psychology & cognitive neuroscience

Anya Topiwala

Department of Psychiatry, University of Oxford

Neuroimaging, longitudinal epidemiological studies, cognition

Martin Turner

Nuffield Department of Clinical Neurosciences, University of Oxford

Blood & CSF analysis, experimental psychology & cognitive neuroscience, imaging, genetics & genomics

Carien van Reekum

School of Psychology and Clinical Language Sciences, University of Reading

Cognitive neuroscience, psychopathology

Michele Veldsman

Nuffield Department of Clinical Neurosciences, University of Oxford

FTD, genetics, stroke

Siv Vingill

Department of Physiology, Anatomy and Genetics, University of Oxford

Transgenic models, cellular and molecular biology, genetics & genomics

Katharina Wagner

Department of Physiology, Anatomy and Genetics, University of Oxford

Transgenic models, translated mRNAs

Richard Wade-Martins

Department of Physiology, Anatomy and Genetics, University of Oxford. Oxford Parkinson's Disease Centre.

Transgenic models, cellular and molecular biology, genetics & genomics

Donald Warden

Department of Pharmacology, University of Oxford

Molecular biology

Frank Wessely

Department of Physiology, Anatomy and Genetics and Department of Pharmacology, University of Oxford

Bioinformatics

Sarah Westwood

Department of Psychiatry, University of Oxford

Blood & CSF analysis

Emma Whiteley

Department of Physiology, Anatomy and Genetics and Department of Pharmacology, University of Oxford

Cellular and molecular biology, electrophysiology (EEG), neuropathology, pharmacology

Gordon Wilcock

Nuffield Department of Clinical Neurosciences,  University of Oxford

Clinical trials, experimental psychology & cognitive neuroscience

Claire Williams

School of Psychology & Clinical Language Sciences at the University of Reading

Behaviour; nutrition & cognition

Sarsha Wilson

Oxford Health NHS Foundation Trust

Clinical care, neurodegeneration

*Laura Winchester

Department of Psychiatry, University of Oxford

Informatics, large scale omics data to identify novel biomarkers

Melanie Witt

Department of Physiology, Anatomy and Genetics, University of Oxford

 ARUK Oxford network administrator

Stephen Wren

Target Discovery Institute, University of Oxford Alzheimer’s drug discovery.

Caroline Woffindale

Translational Neuroscience and Dementia Research Group, University of Oxford

Translational Neuroscience, bioinformatics

Giovanna Zamboni

Nuffield Department of Clinical Neurosciences, University of Oxford

Clinical neurology, neuroimaging, cognition

Ying Zheng*

School of Biological Sciences,  University of Reading

Professor in Systems Engineering and Neuroscience

 

* = new member

 


On this page